4P FDG PET derived metabolic tumor volume (MTV) and its transcriptomic correlates as biomarker to predict efficacy of immune checkpoint inhibitors (ICB) alone or in combination with chemotherapy in advanced NSCLC: A multicentric study

Bibliographische Detailangaben

Veröffentlicht in:	Immuno-oncology technology 2022-12, Vol.16, p.100109, Article 100109
Hauptverfasser:	Dall'Olio, F.G., Garcia, C.A., Zrafi, W.S., Fortunati, E., Bettayeb, A., Zalcman, G., Remon Masip, J., Hendriks, L., Tagliamento, M., Bonardel, G., Helissey, C., Roelants, V., Fourquet, A., Aboubakar, F., Chaput-Gras, N., Passiglia, F., Monnet, I., Planchard, D., Barlesi, F., Besse, B.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!